_________________
Dr Nelson Musoba, the director general of the Uganda AIDS Commission (UAC), has died.
Musoba reportedly died on Sunday morning, November 22, 2026, at Medipal Hospital in Kampala at 5:45am, where he was receiving treatment for cancer-related complications, according to Minister for the Presidency Milly Babalanda.
Babalanda announced Dr Musoba's death on her X (Twitter) social platform, posting, “With deep sorrow and profound sadness, I announce the untimely passing of the Director General of the Uganda AIDS Commission, Dr Musoba. I hereby convey this sad news to H.E. the President of the Republic of Uganda, Gen. (Rtd.) Yoweri Kaguta Museveni, the staff of the Uganda AIDS Commission and the entire nation.”
“His passing comes at a particularly critical time as the country prepares to commemorate World AIDS Day (2026) on December 1, a moment when we reflect on the progress made and the challenges that remain in the fight against HIV/AIDS. Dr Musoba's dedication, commitment and invaluable contribution to Uganda's fight against HIV/AIDS will forever be remembered. His distinguished service to the nation and tireless efforts towards strengthening the national HIV/AIDS response have left an enduring legacy that will continue to inspire those working towards a healthier Uganda,” Babalanda posted.
On behalf of the Office of the President, she extended her heartfelt condolences to the bereaved family, the management and staff of the Uganda AIDS Commission, friends, colleagues and all stakeholders in the fight against HIV/AIDS.
Babalanda said further information regarding the burial arrangements would be communicated in due course.
'Devastating loss'
Dr Vincent Bagambe, the head of planning, policy and strategic information at UAC, described Musoba's death as a devastating loss to the institution, saying he had provided strategic leadership and direction to the commission.
“It is a very dark morning, and we are yet to come to terms with it as a team that Nelson has been leading. He has been a strategic leader, guiding the commission towards achieving the goal of ending AIDS as a public health threat in Uganda,” Bagambe said.
Bagambe described Musoba as a technically skilled leader who understood the work of the commission and maintained close relationships with staff.
“He was a people person. He was technically skilled. He knew what to do. He was a good team leader for us,” Bagambe said.
Bagambe said Musoba had been unwell for some time and had received treatment at different health facilities, including outside Uganda.
“He has not been well for a while, maybe for about a year now. He was receiving treatment from different facilities. At one time, he even received treatment out of the country,” he said.
However, Bagambe said he was not directly involved in Musoba's treatment and that further details about his illness would have to come from the family.
Who is Dr Musoba?
Musoba joined the Uganda AIDS Commission in 2014 as director of planning and strategic information. He was appointed Acting Director General, Uganda AIDS Commission in 2017 and confirmed in February 2018. He was later reappointed in January 2024.
He previously worked as Chief of Party/Project Director for the USAID-funded Monitoring and Evaluation of Emergency Plan Progress (MEEPP) Uganda project supporting the President's Emergency Plan for AIDS Relief (PEPFAR) monitoring and evaluation (2012–2014); Senior Health Planner at Uganda's Ministry of Health (2007–2012), including Global Fund coordination; and Executive Director at Action Group for Health Human Rights and HIV/AIDS (AGHA) Uganda (2003–2006).
The Uganda AIDS Commission is responsible for coordinating and providing strategic direction to the country's multisectoral response to HIV/AIDS, working with government ministries, development partners, civil society organisations and other stakeholders.
Musoba's tenure came at a critical period in Uganda's efforts to reduce new HIV infections, improve access to treatment and prevention services, and achieve the global target of ending AIDS as a public health threat by 2030.